ArticleCancer immunology, immunotherapy : CII2020

Treatment with an immature dendritic cell-targeting vaccine supplemented with IFN-α and an inhibitor of DNA methylation markedly enhances survival in a murine melanoma model.

James T Gordy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.